Hybrid Poly(AMPS-CS)-Au Microneedle Arrays to Enrich Metabolites from Skin for Early Disease Diagnosis

GO-aptamer hydrogel microneedle sensors for the on-site detection of exosomes in interstitial fluid on acupuncture treatment

Acupuncture treatment had achieved good clinical effects on treat or ameliorate chronic diseases. Exosomes are crucial for transmitting information and network regulation in acupuncture, and their content could be essential for acupuncture's effects. However, there remains a critical need for a highly sensitive approach to detect exosomes in acupuncture therapy studies, particularly for rapid and precise analysis. Herein, a graphene oxide-aptamer hydrogel microneedle sensor (GOA-HMS) was designed for exosome point of care testing (POCT) on acupuncture treatment. The sensor was fabricated by cross-linking of aminophenylboronic acid (APBA)-modified sodium alginate with chondroitin sulfate and GO nanosheets conjugated with a fluorophore-modified nucleic acid aptamer, in which GO served as a quencher. In the absence of the target exosome, the aptamer binds tightly into the GO, quenching the fluorophore labels. In the presence of exosome, the aptamer binds to the targets, causing a conformational change which alters the distance the fluorescent moieties from the GO, leading to fluorescence recovery and the generation of fluorescent signals. This sensor showed a linear range of 105-109 particles/mL and has a detection limit of 1 particles/mL with an excellent precision of 4.3 % (RSD) for seven repeated detections of 107 particles/mL exosome, demonstrating the feasibility of both point-of-care clinical diagnostics and high throughput. Meanwhile, typical enzyme-linked immunosorbent assay (ELISA) assay further verified the measurement accuracy by this GOA-HMS. The GOA-HMS was successfully applied to exosome detection in acupuncture treatment, providing a non-invasive, in situ tool for monitoring patient responses in real-time and investigating acupuncture mechanisms.

High Strength, Strain, and Resilience of Gold Nanoparticle Reinforced Eutectogels for Multifunctional Sensors

Eutectogels with inherent ionic conductivity, mechanical flexibility, environment resistance, and cost-effectiveness have garnered considerable attention for the development of wearable devices. However, existing eutectogels rarely achieve a balance between strength, strain, and resilience, which are critical indicators of reliability in flexible electronics. Herein, poly(sodium styrenesulfonate) (PSS)-modified gold nanoparticles (AuNPs) in eutectic solvents are synthesized, and PSS-AuNP reinforced polyacrylic acid/polyvinylpyrrolidone (SAu-PAA/PVP) eutectogel is successfully prepared. Through the coordination between AuNPs and the PAA/PVP polymer chains, the SAu-PAA/PVP eutectogel exhibits significantly enhanced tensile strain (946%), mechanical strength (3.50 MPa), and resilience (85.3%). The high-performance eutectogel was demonstrated as a flexible sensor sensitive to strain and temperature, and the AuNPs provided near-infrared sensing capabilities. Furthermore, SAu-PAA/PVP eutectogel inherits the benefits of ES, including anti-drying and anti-freezing properties (-77 °C). Moreover, the eutectogel is microstructured using a simple molding method, and the resulting hierarchical pyramid microstructured eutectogel functions as ionic dielectric layer in a pressure sensor. This sensor exhibits high sensitivity (37.11 kPa-1), low detection limit (1 Pa), a fast response rate (36/54 ms), and excellent reproducibility over 5000 cycles, making them reliable and durable for detecting small vibrations, with potential applications in precision machinery, aerospace, and buildings.

Functionalized DNA Origami-Enabled Detection of Biomarkers

Biomarkers are crucial physiological and pathological indicators in the host. Over the years, numerous detection methods have been developed for biomarkers, given their significant potential in various biological and biomedical applications. Among these, the detection system based on functionalized DNA origami has emerged as a promising approach due to its precise control over sensing modules, enabling sensitive, specific, and programmable biomarker detection. We summarize the advancements in biomarker detection using functionalized DNA origami, focusing on strategies for DNA origami functionalization, mechanisms of biomarker recognition, and applications in disease diagnosis and monitoring. These applications are organized into sections based on the type of biomarkers - nucleic acids, proteins, small molecules, and ions - and concludes with a discussion on the advantages and challenges associated with using functionalized DNA origami systems for biomarker detection.

Wearable Clinic: From Microneedle-Based Sensors to Next-Generation Healthcare Platforms

The rapid development of wearable biosensing calls for next-generation devices that allow continuous, real-time, and painless monitoring of health status along with responsive medical treatment. Microneedles have exhibited great potential for the direct access of dermal interstitial fluid (ISF) in a minimally invasive manner. Recent studies of microneedle-based devices have evolved from conventional off-line detection to multiplexed, wireless, and integrated sensing. In this review, the classification and fabrication techniques of microneedles are first introduced, and then the representative examples of microneedles for transdermal monitoring with different sensing modalities are summarized. State-of-the-art advances in therapeutic and closed-loop systems are presented to formulate guidelines for the development of next-generation microneedle-based healthcare platforms. The potential challenges and prospects are discussed to pave a new avenue toward pragmatic applications in the real world.

Where Microneedle Meets Biomarkers: Futuristic Application for Diagnosing and Monitoring Localized External Organ Diseases

Extracellular tissue fluids are interesting biomatrices that have recently attracted scientists' interest. Many significant biomarkers for localized external organ diseases have been isolated from this biofluid. In the diagnostic and disease monitoring context, measuring biochemical entities from the fluids surrounding the diseased tissues may give more important clinical value than measuring them at a systemic level. Despite all these facts, pushing tissue fluid-based diagnosis and monitoring forward to clinical settings faces one major problem: its accessibility. Most extracellular tissue fluid, such as interstitial fluid (ISF), is abundant but hard to collect, and the currently available technologies are invasive and expensive. This is where novel microneedle technology can help tackle this significant obstacle. The ability of microneedle technology to minimally invasively access tissue fluid-containing biomarkers will enable ISF and other tissue fluid utilization in the clinical diagnosis and monitoring of localized diseases. This review attempts to present the current pursuit of the application of microneedle systems as a diagnostic and monitoring platform, along with the recent progress of biomarker detection in diagnosing and monitoring localized external organ diseases. Then, the potential use of various microneedles in future clinical diagnostics and monitoring of localized diseases is discussed by presenting the currently studied cases.

Microneedle Array Encapsulated with Programmed DNA Hydrogels for Rapidly Sampling and Sensitively Sensing of Specific MicroRNA in Dermal Interstitial Fluid

Author: Please verify that the changes made to improve the English still retain your original meaning.Detection of microRNA (miRNA) in dermal interstitial fluid (ISF) has emerged as clinically useful in health status monitoring. However, it remains a great challenge owing to the difficult sampling and low abundance. Here, we report a DNA hydrogel microneedles (MNs) array to realize rapid enrichment and sensitive detection of miRNA in ISF. The MNs' patch consists of methacrylate hyaluronic acid (MeHA) equipped with a smart DNA circuit hydrogels' system (MeHA/DNA), in which an appropriate miRNA input enables triggering a cascading toehold-mediated DNA displacement reaction to catalytically cleave cross-linking points to generate amplified fluorescence (FL) for miRNA detection. The MeHA/DNA-MNs patch with high mechanical strength can extract adequate ISF in a short time (0.97 ± 0.2 mg in 5 min) in vivo because of its supreme water affinity. Additionally, the cascading toehold-mediated DNA displacement signal amplification reaction allows for sensitive detection of the low-abundant miRNAs down to 241.56 pM. The DNA hydrogels' MNs present potential for minimally invasive personalized diagnosis and real-time health monitoring in clinical applications.

Recent Progress in Microneedles-Mediated Diagnosis, Therapy, and Theranostic Systems

Theranostic system combined diagnostic and therapeutic modalities is critical for the real-time monitoring of disease-related biomarkers and personalized therapy. Microneedles, as a multifunctional platform, are promising for transdermal diagnostics and drug delivery. They have shown attractive properties including painless skin penetration, easy self-administration, prominent therapeutic effects, and good biosafety. Herein, an overview of the microneedles-based diagnosis, therapies, and theranostic systems is given. Four microneedles-based detection methods are concluded based on the sensing mechanism: i) electrochemistry, ii) fluorometric, iii) colorimetric, and iv) Raman methods. Additionally, robust microneedles are suitable for implantable drug delivery. Microneedles-assisted transdermal drug delivery can be primarily classified as passive, active, and responsive drug release, based on the release mechanisms. Microneedles-assisted oral and implantable drug delivery mechanisms are also presented in this review. Furthermore, the key frontier developments in microneedles-mediated theranostic systems as the major selling points are emphasized in this review. These systems are classified into open-loop and closed-loop theranostic systems based on the indirectness and directness of feedback between the transdermal diagnosis and therapy, respectively. Finally, conclusions and future perspectives for next-generation microneedles-mediated theranostic systems are also discussed. Taken together, microneedle-based systems are promising as the new avenue for diagnosis, therapy, and disease-specific closed-loop theranostic applications.